MoonLake Immunotherapeutics (MLTXN.MX) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-20.45
-17.75
-15.05
-12.35

Details

Expected EPS
-16.915612319999997
Actual EPS
N/A
Surprise EPS
16.92
Surprise Percent
+100%

Description

MoonLake Immunotherapeutics (MLTXN.MX) will report earnings of for Q1 2026 on February 26, 2026.

0 Comments

Share your thoughts